<span item_type="fundamental" item_id="c2acf661e4e064d7ebca67352c2ac688" counter_id="ST/US/SIMAU" env="prod"></span><span item_type="announcement" item_id="516108741327065345" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD 0.07.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not commenced any operations and therefore has not generated any operating revenues as of March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Income</strong>: For the three months ended March 31, 2025, the company reported a net income of $2,222,746, primarily due to interest income earned on the Trust Account amounting to $2,464,218, offset by general and administrative expenses of $241,472.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>General and Administrative Expenses</strong>: Increased from $28,464 for the period from January 29, 2024 (inception) to March 31, 2024, to $241,472 for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: For the three months ended March 31, 2025, net cash used in operating activities was - $185,388.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Interest Income</strong>: Interest earned on cash and marketable securities held in the Trust Account was $2,464,218 for the three months ended March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company intends to effectuate its initial Business Combination using cash from the proceeds of the Initial Public Offering and the Private Placement, among other financing methods. The focus is on companies in the healthcare industry.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>Non-Core Business</strong>: The company has not selected any Business Combination target and may pursue an initial Business Combination in any business or industry.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li><li><strong>Priority</strong>: The company aims to complete the initial Business Combination by July 11, 2026, or cease operations and liquidate if unsuccessful.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/2014982/000121390025043361/ea0240918-10q_simacq1.htm"></span></li></ul>

SIM Acquisition Corp I - Unit | 10-Q: FY2025 Q1 EPS: USD 0.07